» Authors » Walter P Maksymowych

Walter P Maksymowych

Explore the profile of Walter P Maksymowych including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 329
Citations 7716
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Maksymowych W, Lambert R, Bolce R, Bello N, Zhu B, Lisse J, et al.
Lancet Rheumatol . 2025 Feb; PMID: 39983751
Background: The effect of biological disease-modifying antirheumatic drugs (DMARDs) on sacroiliac joint lesions over 52 weeks in biological DMARD-naive patients with radiographic axial spondyloarthritis is unknown. This post-hoc analysis evaluated...
2.
Van den Bosch F, Deodhar A, Poddubnyy D, Maksymowych W, van der Heijde D, Kim T, et al.
Arthritis Res Ther . 2025 Feb; 27(1):23. PMID: 39905436
Background: In SELECT-AXIS 2, upadacitinib improved the signs and symptoms of active non-radiographic axial spondyloarthritis (nr-axSpA) through 52 weeks versus placebo and was well tolerated. Here, we evaluated the efficacy...
3.
Weber U, Seven S, Pedersen S, Ostergaard M, Machado P, Wichuk S, et al.
J Rheumatol . 2025 Feb; PMID: 39892890
Objective: To assess the effect of increasing age on the frequency of inflammatory and structural magnetic resonance imaging (MRI) lesions in the sacroiliac joints (SIJ) in 3 independent cohorts of...
4.
Capelusnik D, Ramiro S, Nikiphorou E, Maksymowych W, Nighat Magrey M, Marzo-Ortega H, et al.
J Rheumatol . 2025 Feb; PMID: 39892889
Objective: We aimed to identify threshold values of presenteeism measurement instruments that reflect unacceptable work state in employed patients with rheumatoid arthritis (RA) and whether those thresholds can predict future...
5.
Mayer A, Brandon T, Aggarwal A, Burgos-Vargas R, Colbert R, Horneff G, et al.
J Rheumatol . 2025 Jan; 52(2):165-172. PMID: 39814440
Objective: To evaluate the influence of pelvic magnetic resonance imaging (MRI) findings on axial disease assessment in juvenile spondyloarthritis (JSpA). Methods: This was a cross-sectional study of patients with JSpA...
6.
Baraliakos X, Deodhar A, van der Heijde D, Van den Bosch F, Magrey M, Maksymowych W, et al.
Rheumatology (Oxford) . 2025 Jan; PMID: 39798135
Objectives: Bimekizumab, a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)‑17F in addition to IL-17A, previously demonstrated efficacy and was well tolerated to 1 year in patients with non-radiographic (nr-)...
7.
Bittar M, Maksymowych W
Curr Rheumatol Rep . 2025 Jan; 27(1):12. PMID: 39777567
Purpose Of Review: The purpose of this publication is to review the role of imaging in axial spondyloarthritis. These findings were presented at the SPARTAN annual meeting in May 2024....
8.
Weiss P, Brandon T, Aggarwal A, Burgos-Vargas R, Colbert R, Horneff G, et al.
Arthritis Care Res (Hoboken) . 2024 Dec; PMID: 39721765
Objective: The Paediatric Rheumatology International Trials Organisation (PRINTO) recently undertook an effort to better harmonize the pediatric and adult arthritis criteria. These provisional criteria are being refined for optimal performance....
9.
Ostergaard M, Boesen M, Maksymowych W, Lambert R, Bubb M, Kubassova O, et al.
Lancet Rheumatol . 2024 Nov; 7(2):e118-e126. PMID: 39488216
Background: The Psoriatic Arthritis Magnetic Resonance Imaging Scoring System (PsAMRIS) and MRI Whole-Body Scoring System for Inflammation in Peripheral Joints and Entheses in Inflammatory Arthritis (MRI-WIPE) have not been used...
10.
Birck M, Lukusa L, Choquette D, Boire G, Maksymowych W, Singh H, et al.
BMC Rheumatol . 2024 Sep; 8(1):47. PMID: 39343928
Background: Safety remains a significant concern for biologic drugs, and studies are needed to ensure a comparable safety profile for biosimilars and their legacy treatments. Using Canadian administrative health data...